Regina Kogan
Obstetrics & Gynecology · Brooklyn, NYNPI 1851603575
Payments from drug & device makers
Across 95 payments — averaging $25.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$375
- Biohaven Pharmaceutical Holding Company Ltd.$300
- Exeltis, USA Inc.$219
- AbbVie$218
- Myovant Sciences Inc.$197
- Avion Pharmaceuticals$188
- plus $919 from 18 others
What the payments were for
- Food & beverage$2,22292%
- Education$1948%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 7 | $375 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $300 |
| Exeltis, USA Inc. | 11 | $219 |
| AbbVie | 5 | $218 |
| Myovant Sciences Inc. | 5 | $197 |
| Avion Pharmaceuticals | 13 | $188 |
| Pfizer | 7 | $147 |
| Ascend Therapeutics US, LLC | 1 | $103 |
| Evofem Biosciences, Inc. | 5 | $99 |
| Shield Therapeutics Inc | 3 | $81 |
| Sumitomo Pharma America, Inc. | 4 | $81 |
| Aspira Women's Health Inc | 4 | $64 |
| Coopersurgical, Inc. | 3 | $56 |
| Agile Therapeutics, Inc. | 3 | $43 |
| Organon | 3 | $41 |
| Biogen | 2 | $38 |
| Bayer | 2 | $38 |
| Radius Health, Inc. | 1 | $26 |
| Mycovia Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Scynexis, Inc. | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Mission Pharmacal Company | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,416 in reported general payments places this provider in the 80th percentile of 2,673 obstetrics & gynecology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 26 | $750 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $278 |
| Alendronate Sodium | 12 | $60 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Brooklyn
- Miriam CremerBrooklyn$196K
- Michael LewisBrooklyn$62K
- Kathleen MorrellBrooklyn$48K
- Ila DayanandaBrooklyn$43K
- Yi-Chun LeeBrooklyn$38K
- Mark DefazioBrooklyn$27K
- Marina FrimerBronx$8.5M
- Nicole NevadunskyBronx$2.5M
- Jin Hee KimNew York$1M
- Carolyn WesthoffNew York$935K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.